ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Auto-immunity"

  • Abstract Number: 1902 • 2013 ACR/ARHP Annual Meeting

    Characterization Of HLA-DRB1 Distribution By 3rd Hypervariable Region Sequence In Systemic Sclerosis and Control Populations

    Coline, A. Gentil1, Hilary S. Gammill1, Christine, T. Luu1 and J. Lee Nelson2, 1Immunogenetics, Fred Hutchinson Cancer Research Center, SEATTLE, WA, 2Immunogenetics D2-100, Fred Hutchinson Cancer Rsch, Seattle, WA

    Background/Purpose: HLA class II genes are associated with a wide spectrum of autoimmune diseases.  Specific alleles at the DRB1, DQA1 and DQB1 loci are associated…
  • Abstract Number: 1792 • 2013 ACR/ARHP Annual Meeting

    Inhibition Of Chemokine Receptors CCR1 and CCR6 As Promising Therapies For Autoimmune Diseases Such As Rheumatoid Arthritis and Psoriasis

    Daniel Dairaghi1, Penglie Zhang2, Manmohan Leleti2, Robert Berahovich3, Karen Ebsworth3, Linda Ertl3, Shichang Miao4, Zhenhua Miao3, Lisa Seitz3, Joanne Tan3, Matthew Walters3, Yu Wang3, Jay Powers5, Thomas J. Schall6 and Juan C. Jaen7, 1Biology, ChemoCentryx, Inc., Mountain View, CA, 2Chemistry, ChemoCentryx, Mountain View, CA, 3Biology, ChemoCentryx, Mountain View, CA, 4Pharmacokinetics, ChemoCentryx, Inc., Mountain View, CA, 5ChemoCentryx, Mountain View, CA, 6ChemoCentryx, Inc., Mountain View, CA, 7Discovery and Preclinical Development, ChemoCentryx, Inc., Mountain View, CA

    Background/Purpose:  Chemokines are key regulators of leukocyte activation and recruitment to sites of inflammation. Of particular relevance in rheumatoid arthritis (RA), the chemokine receptors CCR1…
  • Abstract Number: 1639 • 2013 ACR/ARHP Annual Meeting

    GWAS In Hispanic and Latin American Individuals Enriched For Amerindian Ancestry Identifies a New Locus Associated With Systemic Lupus Erythematosus

    Marta Eugenia Alarcon Riquelme1, Julie T. Ziegler2, Mary E. Comeau3, Elena Sanchez4, Bernado Pons-Estel5, Eduardo Acevedo6, Jorge Mariano Cucho6, Ignacio Garcia de la Torre7, Mario H. Cardiel8, Pedro Miranda9, Luis Cattogio10, Marco Maradiaga11, Jorge Esquivel-Valerio12, Jose F Moctezuma13, Mercedes Garcia14, Guillermo Berbotto15, Alejandra Babini16, Hugo Scherbarth17, Sergio Toloza18, Judith A James19, Teresa Tusie-Luna20, John B Harley21, Raphael Zidovetski22, Carl Langefeldt2 and Chaim O. Jacob23, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Wake Forest University Health Sciences, Winston-Salem, NC, 4King's College London, London, United Kingdom, 5Hospital Provincial de Rosario, Rosario, Argentina, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, 7Hospital General de Occidente, Zapopan, Mexico, 8Centro de Investigacion Clinica de Morelia, Morelia, Mexico, 9Universidad de Chile and Centro de Estudios Reumatologicos, Santiago de Chile, Chile, 10Hospital Italiano, Buenos Aires, Argentina, 11Hospital General de Culiacán, Culiacan, Sinaloa, Mexico, 12Hospital Universitario Dr. José Eleuterio González, Universidad Autonoma de Nuevo León, Nuevo Leon, Mexico, 13Hospital General de Mexico, Mexico, Mexico, 14Hospital San Martin, La Plata, Argentina, 15Hospital Eva Peron, Granadero Baigorria, Argentina, 16Hospital Privado de Cordoba, Cordoba, Argentina, 17H.I.G.A. Oscar E. Alende, Mar del Plata, Argentina, 18Hospital San Juan Bautista, Catamarca, Argentina, 19Oklahoma Medical Research Foundation, Oklahoma City, OK, 20Instituto de Investigaciones Biomédicas de la Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 21Childrens Hospital, Cincinnati, OH, 22University of Southern California, Los Angeles, CA, 23Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: Systemic lupus erythematosus (SLE), a chronic autoimmune disease with a strong genetic component, exhibits a 9:1 female to male ratio and disproportionate impact on…
  • Abstract Number: 1621 • 2013 ACR/ARHP Annual Meeting

    T Helper 17 Cells and Interferon Type I: Partners In Crime In SLE?

    Odilia B.J. Corneth1, Zana Brkic2, Cornelia G. van Helden-Meeuwsen3, Radboud J.E.M. Dolhain4, Naomi I. Maria3, Sandra M.J. Paulissen4, Nadine Davelaar5, Jan Piet van Hamburg5, Paul L. Van Daele3, Virgil A. Dalm2, Martin van Hagen3, Marjan A. Versnel2 and Erik Lubberts6, 1Rheumatology and Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 2Erasmus Medical Center, Immunology, Rotterdam, Netherlands, 3Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 5Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 6Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

    Background/Purpose: A hallmark of systemic autoimmune diseases, such as systemic lupus erythematotsus (SLE), is the increased expression of interferon (IFN) type I inducible genes, the…
  • Abstract Number: 628 • 2013 ACR/ARHP Annual Meeting

    Estrogen Modulates The Expression Of Endosome-Associated Toll-Like Receptor 8 Through Estrogen Receptor-α Which May Contribute To Sex-Bias In Systemic Lupus Erythematosus

    Nicholas A. Young1, Lai-Chu Wu1, Craig Burd2, Alexandra Friedman1, Benjamin Kaffenberger1, Murugesan Rajaram3, Larry S. Schlesinger4, Hayley James5, Margaret Shupnik6 and Wael N. Jarjour7, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Molecular Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, 3Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, 4Center for Microbial Interface Biology, The Ohio State University Wexner Medical Center, Columbus, OH, 5Asthma, Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, VA, 6Endocrinology; Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, 7Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Epidemiological data suggests that females of child-bearing age are more resistant to infectious disease.  The sex hormone estrogen (E2) is present at elevated levels…
  • Abstract Number: 632 • 2013 ACR/ARHP Annual Meeting

    Anti-Ribosomal-Phosphoprotein Autoantibodies Penetrate Into Neuronal Cells Via Neuron Growth Associated Protein (GAP43)

    Shaye Kivity1, Yehuda Shoenfeld2, Margalit Zusev3, Inna Slutsky4, Dolores J Cahill5, Sara Louise O'Kane6, Michal Harel-Meir7, María Teresa Arango8, Juan-Manuel Anaya9, Joab Chapman10 and Miri Blank11,12, 1Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affliated to Sackler Faculty of Medicine, Tel-Aviv University Israel, Tel-Aviv, Israel, 2Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel, 3Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Israel, Ramat Gan, Israel, 4Department of Physiology and Pharmacology, Sackler Faculty of Medicine,, Tel-Aviv, Israel, 53School of Medicine and Medical Sciences, Conway Institute of Biomolecular & Biomedical Research, University College, Dublin, Ireland, 6School of Medicine and Medical Sciences, Conway Institute of Biomolecular & Biomedical Research, University College, Dublin, Ireland, 7Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Tel-Aviv, Israel, 8Doctoral Program in Biomedical Sciences Universidad del Rosario, Bogota, Colombia;Center for Autimmune Diseases Research – CREA, Universidad del Rosario,, Bogota, Colombia, 9Center for Autoimmune Diseases Research (CREA), Universidad del Rosario., Bogota, Colombia, 10Department of. Neurology and Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel, 11Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, affiliated to Sackler Medical School, Tel Aviv University, Ramat Gan, Israel, 12Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine,Tel Aviv University, Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Autoantibodies targeting ribosomal phosphoproteins (anti-Ribos.P) are detected in the sera of  10-45%  patients with  neuropsychiatric-systemice-lupus-erythemathosus-(NPSLE) and correlate with disease-activity. Intracerebroventricular administration of anti-Ribos.P induce…
  • Abstract Number: 638 • 2013 ACR/ARHP Annual Meeting

    Estrogen-Induced STAT1 and STAT4 Expression Is Estrogen Receptor α Dependent and IFNα Independent: A Novel Mechanism For Sex-Bias In Systemic Lupus Erythematosus Pathogenesis?

    Nicholas A. Young1, Giancarlo R. Valiente2, Lai-Chu Wu1, Michael Bruss3, Craig Burd4 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Medical Scientist Training Program, The Ohio State University College of Medicine, Columbus, OH, 3Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Molecular Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a devastating multi-organ autoimmune disease displaying an overwhelming female predilection. Estrogen (E2) influences gene expression by binding to estrogen…
  • Abstract Number: 547 • 2013 ACR/ARHP Annual Meeting

    Anti Ribosomal P  Antibodies Accelerate Lupus Glomerulonephritis and Induce Lupus Nephritis In Naive Mice

    Dana Ben-Ami Shor1, Miri Blank2, Sandra Reuter3, Torsten Matthias4, Alexander Volkov5, Iris Barshack6 and Yehuda Shoenfeld7, 1Zabludowicz Center for Autoimmune Diseases, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine,Tel Aviv University, Tel-Aviv, Tel-Aviv, Israel, 3AIRA e.V., AESKU.KIPP Institute, Wendelsheim, Germany, 4AESKU.Diagnostics GmbH & Co. KG, Wendelsheim, Germany, 5Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Tel-Aviv, Israel, 6Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel, 7Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Circulating anti-phosphoribosomal protein antibodies (anti-Ribos.P) were found to be associated with lupus nephritis. We have assessed the direct role of anti-Ribos.P in the development…
  • Abstract Number: 979 • 2012 ACR/ARHP Annual Meeting

    Cell-Type Specific Type I Interferon Signatures in Systemic Lupus Erythematosus and Viral Infection: What Makes the Difference?

    Chieko Kyogoku1, Joachim R. Grün1, Tobias Alexander2, Robert Biesen3, Falk Hiepe4, Thomas Häupl3, Andreas Radbruch1 and Andreas Grützkau1, 1German Rheumatism Research Centre Berlin (DRFZ), an institute of the Leibniz Association, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 3department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

    Background/Purpose: Gene expression profiling experiments using peripheral blood mononuclear cells (PBMCs) revealed a crucial role of type I interferon (IFN) in the pathogenesis of systemic…
  • Abstract Number: 685 • 2012 ACR/ARHP Annual Meeting

    Using a Library of Synthetic Autoantigen Mimics to Discover Biomarkers of Systemic Lupus Erythematosus

    Akshai Lakhanpal1, Jiexia Quan2, Sayed Zaman1, Nancy J. Olsen3 and David R. Karp2, 1Rheumatic Diseases Divsion, UT Southwestern Medical Center, Dallas, TX, 2Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, 3Medicine, Penn State MS Hershey Medical Center, Hershey, PA

    Background/Purpose:   The natural history of systemic lupus erythematosus (SLE) is felt to evolve from a state of normal immunity to serologic autoimmunity and then…
  • Abstract Number: 686 • 2012 ACR/ARHP Annual Meeting

    Cell-Type Specific Type I Interferon Signatures in Autologous Stem Cell Transplanted Lupus Patients: Different Molecular Behavior Between CD4+ T Cells and Monocytes

    Chieko Kyogoku1, Joachim R. Grün1, Tobias Alexander2, Robert Biesen3, Falk Hiepe4, Thomas Häupl3, Andreas Radbruch1 and Andreas Grützkau1, 1German Rheumatism Research Centre Berlin (DRFZ), an institute of the Leibniz Association, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 3department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects multiple organs, whose pathology is mainly caused by the augmented interferon (IFN)…
  • Abstract Number: 670 • 2012 ACR/ARHP Annual Meeting

    Prolidase Deficiency Induces Antibodies to Sm, Ro60 and Double Stranded DNA

    Biji T. Kurien1, Anil D'souza2, Skyler P. Dillon1, Benjamin F. Bruner3, Timothy Gross4, Judith A. James5, Ira N. Targoff6, Jacen S. Maier-Moore7, Isaac T.W. Harley8, Heng Wang9 and Robert H. Scofield7, 1Department of Medicine, Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 2Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Harding University, Searcy, AR, 4Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Arthritis and Immunology, Oklahoma Medical Research Foun, Oklahoma City, OK, 7Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 8Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, 9Das Deutsch Center Clinic for Special Needs Children, Middlefield, OH

    Background/Purpose: Prolidase is a ubiquitous enzyme found in the cytoplasm.  The enzyme specifically cleaves dipeptides containing C-terminal proline or hydroxyproline, in one of the last…
  • Abstract Number: 201 • 2012 ACR/ARHP Annual Meeting

    High Rate of Autoimmune Manifestations During Idiopathic CD4 Lymphocytopenia

    Alexis Régent1, Brigitte Autran2, Guislaine Carcelain2, Benjamin Terrier3, Alain Krivitzky4, Eric Oksenhendler5, Nathalie Costedoat-Chalumeau6, Pascale Hubert2, Olivier Lortholary7, Nicolas Dupin8, Patrice Debré2, Loic Guillevin9 and Luc Mouthon1, 1Internal Medicine, Hopital Cochin, Paris, France, 2INSERM, UMR945, AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire d'Immunologie Cellulaire Et Tissulaire, Paris, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 4Département de médecine interne, Hôpital Avicenne, AP-HP, Bobigny, France, 5Département d'Immunologie Clinique, Hôpital Saint-Louis, AP-HP, Paris, France, 6Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, 7Service de maladies infectieuses, Hôpital Necker-Enfants malades, AP-HP, Paris, France, 8Service de Dermatologie, Hôpital Cochin, AP-HP, Paris, France, 9Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France

    Background/Purpose: When first described by the Center for Disease Control, idiopathic CD4 lymphocytopenia (ICL) was characterized by opportunistic infections in patients with a CD4 count≤300/mm3…
  • Abstract Number: 27 • 2012 ACR/ARHP Annual Meeting

    Anti-Citrullinated Protein Antibodies As an Indicator of Bone Damage in the Citrullinated Collagen Induced Arthritis Model

    Anand Dusad1, Michael J. Duryee2, Dong Wang3, Carlos D. Hunter2, Bartlett C. Hamilton III4, James R. O'Dell5, Ted R. Mikuls6, Lynell W. Klassen5 and Geoffrey M. Thiele7, 1Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3Pharmaceutical Sciences, Univ of Nebraska Medical Ctr, Omaha, NE, 4University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 5Dept of Internal Medicine, Univ of Nebraska Med Ctr, Omaha, NE, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE

    Background/Purpose: Although the pathogenesis and cause of rheumatoid arthritis (RA) remains uncertain, various disease-driving auto-antigens and auto-antibodies with different specificities have been used as diagnostic…
  • Abstract Number: 2530 • 2012 ACR/ARHP Annual Meeting

    Anti-Ribosomal P Antibodies in a Large Cohort of Autoimmune Hepatitis with No Evidence of Lupus: A Common Underlying Mechanism Targeting Liver?

    Ana Luisa Calich1, Vilma S. T. Viana1, Eduardo L. Cançado2, Débora R. Terrabuio2, Francisco Tustumi1, Elaine P. Leon1, Clovis Artur Silva3, Eduardo F. Borba Neto1 and Eloisa Bonfa1, 1Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Gastroenterology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy

    Background/Purpose: Anti-ribosomal P proteins antibody (anti-rib P) is a highly specific marker for systemic lupus erythematosus (SLE) and it is associated with liver involvement in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology